Denis Antoine, M.D., FAPA, FASAM, applies the Life Story Perspective to re-think approaches to mental illness and substance use disorder treatments in order to improve individual and societal outcomes.
Roland Griffiths, director of Johns Hopkins Center for Consciousness and Psychedelic Research, describes a milestone study showing that psilocybin relieves major depression.
Karen Swartz, M.D. highlights key findings from national surveys.
Precision medicine tools bring results to patients.
Dr. George Rebok and his research team have developed cognitive or “brain training” interventions to improve function in areas such as memory, problem solving, and speed of processing, which decline with aging and are critical for everyday activities.
Dr. Karin Neufeld is researching the medication ramelteon for the prevention of delirium in older patients undergoing surgery.
Dr. Christopher Ross and his lab are studying the complementary approach to treat Huntington’s disease by developing mouse models, which have progressive symptoms that are similar to those of patients.
Drs. Payne and Osborne lead the Johns Hopkins Women’s Mood Disorders Center, which was established to study hormone-triggered mood disorders and their impact on women.
Dr. Irving Reti, explains the treatment modalities available – electroconvulsive therapy and transcranial magnetic stimulation - the characteristics of each, how to minimize side-effects and manage a patient’s medication.
Angela Guarda, M.D., and her team of researchers are working to understand anorexia nervosa and its addictive nature so they can improve the treatment process.
Lauren Osborne, M.D., and her lab study the biology behind mental illness during and after pregnancy.
Dr. Quincy Miles Samus of the Center for Innovative Care in Aging in the Johns Hopkins University School of Nursing discusses efficacy of a multidimensional home-based care coordination intervention for elders with memory disorders.
Critically ill patients are at increased risk of psychological trauma post-discharge.
Zachary Kaminsky, Ph.D., and his team study chemical modifications of DNA called epigenetic signals, with the aim of using these as a way to predict mental illnesses, like postpartum depression and suicide.
Eric Strain, Ph.D., and his colleagues are developing exciting new therapies for patients who struggle with substance abuse all while expanding their treatment capacity.
After three adolescent suicides in the Baltimore area, the community turned to Johns Hopkins, where Karen Swartz, M.D., and her team developed the Adolescent Depression Awareness Program, known as ADAP.
Featured Articles View All »